Larger size, high nuclear grade, comedo necrosis, ER negativity, PR negativity and HER-2 positive DCIS were more common in patients with RPA3 deficient DCIS (Supplementary Table 8). This evidence concerns the gene RPA3 and ductal breast carcinoma in situ.